| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/14/2007 | EP1761522A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761519A1 Indole derivatives as histamine receptor antagonists |
| 03/14/2007 | EP1761506A1 Substituted quinazolones as anti-cancer agents |
| 03/14/2007 | EP1761505A1 Pyrimidine urea derivatives as kinase inhibitors |
| 03/14/2007 | EP1562936B1 Therapeutic piperazine compounds |
| 03/14/2007 | EP1517895B1 8-(biaryl) quinoline pde4 inhibitors |
| 03/14/2007 | EP1465629B1 5-ht3 receptor antagonists and methods of use |
| 03/14/2007 | CN1930157A Silylierte carboxamide |
| 03/14/2007 | CN1930151A Novel indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug each comprising the same |
| 03/14/2007 | CN1930150A Pyrazolyl indolyl derivatives as PPAR activators |
| 03/14/2007 | CN1930149A Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof |
| 03/14/2007 | CN1930144A 3-'4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 03/14/2007 | CN1930143A MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
| 03/14/2007 | CN1930135A Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
| 03/14/2007 | CN1930133A 苯并咪唑衍生物 Benzimidazole derivatives |
| 03/14/2007 | CN1930132A Ion channel modulators |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1929848A Benzodiazepines for treating or preventing or preventing RSV infection |
| 03/14/2007 | CN1929847A Fasudil-containing preparation and method of improving stability thereof |
| 03/14/2007 | CN1929836A (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 03/14/2007 | CN1929738A Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides |
| 03/14/2007 | CN1304409C Process for producing indolopyrrolocarbazole derivative |
| 03/14/2007 | CN1304380C Benzo[alpha]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/13/2007 | US7189856 Central nervous system disorders; vision defects; antiproliferative agents |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189754 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
| 03/13/2007 | US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders |
| 03/13/2007 | US7189738 Substituted isoindoles and their use thereof |
| 03/13/2007 | US7189729 Methods and compositions as protein kinase inhibitors |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189727 Guanidino compounds |
| 03/13/2007 | US7189724 For therapy of viral diseases |
| 03/13/2007 | US7189722 Aryl spirohydantoin CGRP receptor antagonists |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | CA2274592C Pyrazole derivatives |
| 03/13/2007 | CA2267224C Vitronectin receptor antagonists |
| 03/13/2007 | CA2138452C Substituted 1-arylpyrazoles |
| 03/13/2007 | CA2116388C Treatment for viral diseases |
| 03/08/2007 | WO2007028131A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 03/08/2007 | WO2007028083A2 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | WO2007028082A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | WO2007027842A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 03/08/2007 | WO2007027733A2 Reverse link soft handoff in a wireless multiple-access communication system |
| 03/08/2007 | WO2007026962A1 Phenylene derivative |
| 03/08/2007 | WO2007026834A1 Pyrazole derivatives and herbicides for agricultural and horticultural use |
| 03/08/2007 | WO2007026097A1 Novel indole compounds |
| 03/08/2007 | WO2007025901A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | WO2007025899A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | WO2007025775A2 Cysteine protease inhibitors |
| 03/08/2007 | WO2007025774A2 Cysteine protease inhibitors |
| 03/08/2007 | WO2006117307A3 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 03/08/2007 | WO2006067392A3 Indole derivatives for the treatment of tuberculosis |
| 03/08/2007 | WO2004026846A8 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy |
| 03/08/2007 | US20070055081 Processes for production of alpha-aminooxyketones and alpha-hydroxyketones |
| 03/08/2007 | US20070054950 3-Azabicyclo[3.1.0]hexane derivatives |
| 03/08/2007 | US20070054942 N-Cyclopropyl-3-[5-fluoro-3-(4-pyridinyl)-1H-indazol-6-yl]-4-methylbenzamide, useful in the treatment of conditions or disease states mediated by p38 mitogen-activated protein kinase activity or mediated by cytokines produced by the activity of p38 mitogen-activated protein kinases |
| 03/08/2007 | US20070054929 2-Substituted pyrimidines |
| 03/08/2007 | US20070054928 c-Met modulators and methods of use |
| 03/08/2007 | US20070054924 Novel piperidines as chemokine modulators (ccr) |
| 03/08/2007 | US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054921 Substituted indoles and a process for preparing substituted indoles |
| 03/08/2007 | US20070054919 chemokine receptor antagonists used for the therapy of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, ophthalmic inflammation, diabetes, meningitis, tumors and side effect reduction |
| 03/08/2007 | US20070054918 N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 03/08/2007 | US20070054917 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054910 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 03/08/2007 | US20070054909 VLA-4 inhibitor compounds |
| 03/08/2007 | US20070054907 Peroxisome Proliferator-Activated Receptor (PPAR) receptor modulators such as Ethyl(4-{4-[5-(4-tert-butylphenyl)-4-methyl-4H-[1,2,4]-triazol-3-ylsulfanyl]-2-heptyloxybenzylamino}phenyl)acetate, used in dermatology, cardiovascular diseases, immunology and/or diseases linked to lipid metabolism |
| 03/08/2007 | US20070054903 Bis-aryl kinase inhibitors and method |
| 03/08/2007 | US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy |
| 03/08/2007 | US20070054899 Aromatase inhibitor compounds and uses thereof |
| 03/08/2007 | US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054896 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/08/2007 | US20070054895 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 03/08/2007 | US20070054893 Prostaglandin analogs |
| 03/08/2007 | US20070054892 Isoquinoline potassium channel inhibitors |
| 03/08/2007 | US20070051944 Organic electroluminescent element |
| 03/08/2007 | US20070051919 Naphthalene compound with terminal hydrogen, liquid crystal composition including the compound, and lcd device including the liquid crystal composition |
| 03/08/2007 | CA2620818A1 Amide derivatives as rock inhibitors |
| 03/08/2007 | CA2620658A1 Novel indole compounds |
| 03/08/2007 | CA2620425A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 03/08/2007 | CA2620129A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2619919A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2619566A1 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619450A1 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619448A1 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619287A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/07/2007 | EP1760079A1 Compounds as cor5 antagonists |
| 03/07/2007 | EP1760076A1 FAP Inhibitors |
| 03/07/2007 | EP1760075A1 Method for producing acetamidopyrrolidine derivative and intermediate compound thereof |
| 03/07/2007 | EP1758895A1 Gonadotropin releasing hormone receptor antagonists |
| 03/07/2007 | EP1758894A1 Heterocyclic carboxamides with microbiocidal activity |
| 03/07/2007 | EP1758893A1 Substituted diketopiperazines as oxytocin antagonists |
| 03/07/2007 | EP1758892A1 Compounds and compositions as protein kinase inhibitors |
| 03/07/2007 | EP1758891A2 Benzimidazolone carboxylic acid derivatives |
| 03/07/2007 | EP1758890A1 7-pyrazolylbenzazepines having affinity for d3 receptor |
| 03/07/2007 | EP1758868A1 Novel cis-imidazolines |